Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-058081

SVP of Business Development acquired 7,501 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Flowers Lee SVP of Business Development 2023-12-08 Option exercise +7,501 $0.14 $1,050 118,809 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Flowers Lee SVP of Business Development 2023-12-08 Option exercise · Stock Option (Right to Buy) −7,501 0 D: show line 2 in the form
Loading xslF345X05/doc4.xml…